Clonal Distribution of Common Pneumococcal Serotypes Not Included in the 7-Valent Conjugate Vaccine (PCV7): Marked Differences between Two Ethnic Populations in Southern Israel

Pediatric Infectious Disease Unit, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Journal of clinical microbiology (Impact Factor: 4.23). 08/2012; 50(11):3472-7. DOI: 10.1128/JCM.01309-12
Source: PubMed

ABSTRACT This study aimed to compare the clonal distribution of common pneumococcal strains not included in the 7-valent pneumococcal conjugate vaccine (PCV7) that were isolated from cases of acute otitis media (AOM) and invasive pneumococcal disease (IPD) in two distinct ethnic populations in southern Israel during the decade (1999 to 2008) preceding PCV7 implementation. Isolates recovered from Jewish and Bedouin children <5 years old were characterized by antibiotic resistance and molecular epidemiology using pulsed-field gel electrophoresis and multilocus sequence typing. Of 5,236 AOM and 425 IPD isolates, 43% and 57% were from Jewish and Bedouin children, respectively. PCV7 accounted for 54% and 45% of the AOM and IPD episodes, respectively. Eleven major non-PCV7 serotypes (1, 3, 5, 6A, 7F, 12F, 15B/C, 19A, 21, 33F, and 35B) constituted 31% and 42% of the AOM and IPD episodes, respectively. The clonal distributions of the 11 non-PCV7 serotypes and their antibiotic susceptibilities were significantly different among the two ethnic populations in both the AOM and IPD groups. About half of the AOM and IPD cases resulted from non-PCV7 pneumococci, even before PCV7 implementation. The significant differences between the two ethnic populations suggest that lifestyle and microenvironment are major determinants in the clonal distribution of disease-causing pneumococci. Post-PCV7 surveillance is important in understanding non-PCV7 clonal expansion in the two distinct populations.

Download full-text


Available from: Noga Givon-Lavi, Jan 01, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: After the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in Alaska, the incidence of invasive pneumococcal disease (IPD) due to non-vaccine serotypes, particularly serotype 19A, increased. The aim of this study was to describe the molecular epidemiology of IPD due to serotype 19A in Alaska. IPD data were collected from 1986 to 2010 through population-based laboratory surveillance. Isolates were serotyped by the Quellung reaction and MICs determined by broth microdilution. Genotypes were assessed by multilocus sequence typing. Among 3,294 cases of laboratory-confirmed IPD, 2,926 (89%) isolates were available for serotyping, of which 233 (8%) were serotype 19A. Across all ages, the proportion of IPD caused by serotype 19A increased from 3.5% (63/1823) pre-PCV7 (1986-2000) to 15.4% (170/1103) post-PCV7 (2001-2010) (p<0.001); among children <5 years of age, the proportion increased from 5.0% (39/776) to 33.0% (76/230) (p<0.001). The annual incidence rate of IPD due to serotype 19A (all ages) increased from 0.73 cases pre-PCV7 to 2.56 cases/100,000 persons post-PCV7 (p<0.001); rates among children <5 years of age increased from 4.84 cases to 14.1 cases/100,000 persons (p<0.001). Among all IPD isolates with reduced susceptibility to penicillin, 17.8% (32/180) were serotype 19A pre-PCV7 and 64% (121/189) were serotype 19A post-PCV7 (p<0.001). Eighteen different sequence types (STs) were identified; ST199 or single locus variants of ST199 (n=150) and ST172 (n=59) accounted for the majority of isolates. Multidrug-resistant isolates were clustered in ST199 and ST320. While PCV13 should significantly reduce the burden of disease due to 19A, these data highlight the need to continue surveillance for IPD to monitor the effects of vaccination on the expansion and emergence of non-PCV strains.
    08/2013; 72. DOI:10.3402/ijch.v72i0.20854
  • [Show abstract] [Hide abstract]
    ABSTRACT: The Bedouins comprise one of the ethnic groups in Israeli society. They are Muslims, most of who live in the Negev desert region of southern Israel and live by their unique traditions and customs. At the present they are going through a period of "society in transition", a unique condition that has ramifications for health and morbidity. In recent years the number of publications on the health of Bedouins in the Negev has increased. Recognition of unique socio-economic features, characteristics of health and diseases can help the medical team treat various health problems in this population as well as other populations with similar characteristics. In the present paper we survey and discuss publications on the health of Bedouin children over the past 20 years.
    Journal of Immigrant and Minority Health 03/2014; 17(3). DOI:10.1007/s10903-014-0001-3 · 1.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, we analyzed the clinical and molecular epidemiology of invasive serotype 5 (Ser5) pneumococcal isolates, in four teaching Hospitals in the Barcelona area (1997-2011 period). Among 5,093 invasive pneumococci collected, 134 (2.6%) Ser5 were detected. Although the overall incidence of Ser5 IPD was low (0.25 cases/100,000 inhabitants), three incidence peaks were detected: 0.63/100,000 in 1999, 1.15/100,000 in 2005 and 0.37/100,000 in 2009. Rates of Ser5 IPD were higher among young adults (18-64 years) and older adults (over 64 years) in the first two peaks, whereas they were higher among children in 2009. The majority (88.8%) of patients had pneumonia. Co-morbid conditions were present in young (47.6%) and older adults (78.7%), the most common being chronic obstructive pulmonary disease (20.6% vs 38.3%, respectively) and cardiovascular diseases (11.1% vs 38.3%, respectively). Mortality rates were higher among older adults (8.5%). All Ser5 pneumococci were fully susceptible to penicillin, cefotaxime, erythromycin, and ciprofloxacin. The resistance rates were: cotrimoxazole (48.5 %), chloramphenicol (6.7%) and tetracycline (6%). Two major related sequence types (STs) were detected: ST1223 (n=65), and ST289 (n=61). The Colombia(5)-ST289 clone was responsible for all the cases of the Ser5 outbreak in 1999, whereas ST1223 clone accounted for 73.8% and 61.5% of isolates in 2005 and 2009, respectively. Ser5 pneumococci are a frequent cause of IPD outbreaks in the community involving children and adults with or without co-morbidities. The implementation of the new pneumococcal conjugated-vaccines (PCV10 and PCV13) could prevent such outbreaks.
    Journal of clinical microbiology 08/2013; 51(11). DOI:10.1128/JCM.01538-13 · 4.23 Impact Factor